Manufactured by Pharmacy Sterile Production Unit (Unlicensed Product) At SFH: Subconjunctival injection 7.5mg in 0.3mL (Prescribed when 5mg/ 0.2ml is required) or 50mg/1ml prepared by Aseptic dispensing unit (x3169)
Available as: - Eye drops 0.04%(preservative free) (Multi dose bottles)- NUH only - Solution for sub-conjunctival use 0.2mg in 1mL - Solution for sub-conjunctival use 0.4mg in 1mL (and several other concentrations at KMH aseptic unit)
Sub-conjunctival injection manufactured by Pharmacy Sterile Production Unit (Unlicensed Products)
Manufactured by Pharmacy Sterile Production Unit (Unlicensed Product) Lower strengths available upon request
Glues - ocular
Oily eye drops 2% (Unlicensed Product), formulated in arachis oil. Avoid in peanut allergy Eye ointment 0.2% (Unlicensed Vetinary Product, Optimmune®)used only as alternative when 2% drops unavailable. Preservative free but contains lanolin
both specialist use at NUH only
2% eye ointment = non-formulary
0.05% preservative free = non-formulary
0.06% preservative free multidose = non-formulary
Neoral® for Uveitis
Ikervis® 0.1% eye drops single use- Subject of NICE TA369 - see link below for information sheet
Verkazia® 0.1% eye drops for vernal keratoconjuntivitis licensed for children (over 4years old) and adolecents (not adults) = - see link below for information sheet
Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data. Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting. Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.
Medicines which should normally be prescribed by specialists only. eg hospital only.
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.
Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
*Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice
Primary care/ non specialist may initiate as per APC guideline.
The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.
Medicines suitable for routine use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.